BUSINESS INSIGHTS

Prescribing

Advancing the understanding
of indication-level, sub-national high-cost drug prescribing

Verpora VSTx

Data analyst
Family health

VSTx delivers accurate, granular visibility of high-cost drug prescribing at indication-level across UK secondary care organisations. It translates complex trust and health board-level data into structured insight to support resource allocation, forecasting and strategic planning for sustained market leadership.

VSTx enables detailed analysis of drug use by indication across the brand lifecycle, spanning new patient share dynamics, total product use at market or molecule level, and patients’ duration of therapy.

VSTx insight informs confident decision-making across key business functions

Market Access & Pricing

Use VSTx to clarify standards of care and variation across indications, supporting assessment of access equity, relevant comparator selection, and informed pricing and payer negotiations.

HEOR

Use VSTx to highlight variation in product use by indication, and whether patients are benefiting as expected across the UK to enable alignment with approved guidance.

Brand

Use VSTx to align and optimise promotional resource by indication, and predict and monitor sales performance to assess promotional effectiveness, and track brand positioning within the treatment pathway across the UK.

Commercial Analytics & BI

Use VSTx to differentiate KPIs by indication, forecast and monitor sales for new and existing indications, assess competitive impact on patient share, and segment accounts accurately by indication rather than total brand sales.

Sales & Account Management

Use VSTx to compare product use by indication across accounts, monitor new patient share by indication, and identify early indicators of performance against targets.

Medical Affairs

Use VSTx to compare therapeutic choices across accounts, assess treatment variation by indication, and understand whether patients remain on therapy for the expected duration.

Market Indication Reports

VERPORA VSTx


Verpora VSTx market indication reports demo charts - example national level therapy area by brand, and patient numbers by trust

Gain competitive advantage. Act with confidence. Grow your indication share

Precision insights into own and competitor product use for each indication.

Molecule Indication Reports

VERPORA VSTx


Understand your molecule’s footprint, maximize lifecycle value and optimise cross-indication strategy

Verpora VSTx Molecule Indication Reports demo charts - immunology product patients numbers by indication

Total visibility of patient share across all indications for your molecule.

“Making meaningful change to our sales forecasting model, that would be accepted throughout the organisation, required evidence for our hypothesis around dosage and persistence. Partnering with Verpora was critical to providing that evidence.”

Business Insights Lead, Top-5 Pharmaceutical Company

New Patient Share

VERPORA VSTx


Verpora New Patient Share Demo - showing nps by date and brand comparison

Turn lead indicators into
market leadership

Identification of new patient starts by indication for your and your competitor's products.

Therapy Duration Report

VERPORA VSTx


Verpora VSTx Therapy Duration report demo charts - product X persistence by start date

Refine forecasts and identify exactly where to intervene to improve patient retention

Real-world data into patients' duration of therapy by indication.

Ready to talk through your VSTx use case? Let’s arrange a call…

Business Insights Team

Lead by experienced analysts supported by a team of pharmacists, data engineers and developers.

Jenny Dawson
VP Business Insights and Analytics

Read more

Rob Heathcote
VP Data & Analytics

Read more

Adam Buckler
eRx Pharmacist,
Royal Marsden

Read more

Specialist Insight Projects

In addition to VSTx, we undertake custom research and analytical work across UK, US and global markets, spanning payer research, patient journey data and advanced performance analytics.

For tailored insight or a specific project enquiry, contact wanda.lesowiec@verpora.com

group of people icon

US-focused patient burden and treatment journey analysis to support value demonstration and access planning.

Structured qualitative research with Verpora's payer network to inform pricing, access and positioning strategy.

Performance Analytics

Custom Research

Advanced segmentation, targeting, resource allocation and forecasting analysis to support data-led commercial decision-making.

Quantitative research and evidence-generation projects designed to address specific commercial or strategic questions.

Payer Research

VMBA Patient Burden & Journey Data

Arrange an initial conversation to help us understand your priorities and context, and how VSTx can start solving your greatest challenges.

Wanda Lesowiec
VP Commercial Accounts

Email wanda.lesowiec@verpora.com